Orphazyme A/S
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Orphazyme A/S generated cash of -$539,076,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,159,422,000 last year. Net change in cash is therefore $603,341,000.
Cash Flow
| 2015 | -46.41M | -495K | 85.75M |
|---|---|---|---|
| 2016 | -54.72M | -238K | 1.3M |
| 2017 | -95.42M | -1.49M | 714.30M |
| 2018 | -234.76M | -2.34M | 0 |
| 2019 | -326.81M | -3.28M | 58.93M |
| 2020 | -539.07M | -5.10M | 1.15B |
ORPH Cash Flow Statement (2015 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 123.58M | 394.70M | 631.73M | 14.34M | 68.01M | 29.16M |
Operating activities | ||||||
Net income | -633.24M | -337.49M | -229.6M | -126.20M | -57.93M | -47.71M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 5.2M | 3.80M | 1.36M | 627K | 706K | 554K |
Stock-based compensation expense | 28.10M | 2.54M | 2.10M | 122K | 0 | 0 |
| Deferred income tax benefit | 28.10M | 2.54M | 2.10M | 122K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -539.07M | -326.81M | -234.76M | -95.42M | -54.72M | -46.41M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -5.10M | -3.28M | -2.34M | -1.49M | -238K | -495K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -5.10M | -3.28M | -2.34M | -1.49M | -238K | -495K |
Financing activities | ||||||
Common Stock Issued | 1.28B | 19K | 0 | 757.91M | 1.33M | 85.97M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -10.53M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 1.15B | 58.93M | 0 | 714.30M | 1.3M | 85.75M |
Net Change In Cash | 603.34M | -271.11M | -237.02M | 617.38M | -53.66M | 38.84M |
Cash at end of period | 726.92M | 123.58M | 394.70M | 631.73M | 14.34M | 68.01M |